Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A4WPI0

Entry ID Method Resolution Chain Position Source
AF-A4WPI0-F1 Predicted AlphaFoldDB

No variants for A4WPI0

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A4WPI0

No associated diseases with A4WPI0

1 regional properties for A4WPI0

Type Name Position InterPro Accession
domain Thiaminase-2/PQQC 23 - 233 IPR004305

Functions

Description
EC Number 1.3.3.11 With oxygen as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
pyrroloquinoline-quinone synthase activity Catalysis of the reaction: 6-(2-amino-2-carboxyethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylate + 3 O(2) = 2 H(2)O + 2 H(2)O(2) + H(+) + pyrroloquinoline quinone.

2 GO annotations of biological process

Name Definition
cellular aromatic compound metabolic process The chemical reactions and pathways involving aromatic compounds, any organic compound characterized by one or more planar rings, each of which contains conjugated double bonds and delocalized pi electrons, as carried out by individual cells.
pyrroloquinoline quinone biosynthetic process The chemical reactions and pathways resulting in the formation of the cofactor pyrroloquinoline quinone (PQQ); it is synthesized from a small peptide containing tyrosine and glutamic acid; these amino acids in the peptide are multiply cross-linked and the rest of the peptide is removed.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSLDLTPTLS PARPLDSADA MEDRLREIGA ARYHDRHPFH HLLHGGQLTR GQVQAWALNR
70 80 90 100 110 120
YYYQCSIPVK DAVVISRFRD RATRVEWRHR LEDHDGAEGT EGGIDRWLVL TDALGLDRDY
130 140 150 160 170 180
VEATDGILPA TRFAVDAYVH FVRDQSPLEA IASCLTELFA PHIHAERISG MLAHYDFVNP
190 200 210 220 230 240
TVMAYFQRRL SQAPRDADYA LRYVREHART PQERAAVCNA LIFKTQVLWT QLDALHHAYV
250
LGHVPPGAFV PEDMR